FDA Warns on Abbott’s St. Jude Pacemakers and Defibrillators
FDA Warns on Abbott’s St. Jude Pacemakers and Defibrillators   
Biography Joseph Walker @joewalkerWSJ joseph.walker@wsj.com The U.S. Food and Drug Administration issued a blistering criticism of Abbott Laboratories for failing to properly investigate and resolve risks related to its implanted heart devices, including cybersecurity threats and a battery malfunction linked to two patient deaths. The FDA made the criticisms in a warning letter sent to Abbott on Wednesday, following an inspection of the medical-device maker’s facilities in Sylmar, Calif., in... Most Popular Videos  Attorney and Daughter of United Passenger Speak  Can Airlines Legally Kick Passengers Off Flights?  Desktop PCs Are Making a Comeback   Trump Sees North Korea as Top Threat    Rent the Clothes Your Children Quickly Outgrow  Most Popular Articles      New York Judge Found Dead in Hudson River        U.S. Drops ‘Mother of All Bombs’ on ISIS in Afghanistan        Trump Threatens to Withhold Payments to Health Insurers        Opinion: The Trump Presidency Begins        Trump and Xi: Tensions Turn to Friendship

The U.S. Food and Drug Administration issued a blistering criticism of Abbott Laboratories for failing to properly investigate and resolve risks related to its implanted heart devices, including cybersecurity threats and a battery malfunction linked to two patient deaths.

The FDA made the criticisms in a warning letter sent to Abbott on Wednesday, following an inspection of the medical-device maker’s facilities in Sylmar, Calif., in...